# Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy

> **NCT00146536** · — · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 78 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00146536
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2017-03-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00146536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00146536, "Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00146536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*